Search

Padmashri Ponnaluri

Examiner (ID: 15202, Phone: (571)272-0809 , Office: P/3991 )

Most Active Art Unit
3991
Art Unit(s)
1648, 1818, 1627, 1639, 3991, 1618
Total Applications
820
Issued Applications
521
Pending Applications
130
Abandoned Applications
175

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 15050943 [patent_doc_number] => RE047672 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-10-29 [patent_title] => Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 [patent_app_type] => reissue [patent_app_number] => 15/697069 [patent_app_country] => US [patent_app_date] => 2017-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 32598 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15697069 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/697069
Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 Sep 5, 2017 Issued
Array ( [id] => 16562689 [patent_doc_number] => RE048389 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2021-01-12 [patent_title] => Antibody drug conjugates (ADC) that bind to 191P4D12 proteins [patent_app_type] => reissue [patent_app_number] => 15/697146 [patent_app_country] => US [patent_app_date] => 2017-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 33 [patent_no_of_words] => 35197 [patent_no_of_claims] => 110 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15697146 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/697146
Antibody drug conjugates (ADC) that bind to 191P4D12 proteins Sep 5, 2017 Issued
15/697074 METHODS OF IMPAIRING OSTEOCLAST DIFFERENTIATION USING ANTIBODIES THAT BIND SIGLEC-15 Sep 5, 2017 Abandoned
90/014003 CRISPR/CAS SYSTEMS FOR GENOMIC MODIFICATION AND GENE MODULATION Aug 23, 2017 Issued
Array ( [id] => 15189749 [patent_doc_number] => RE047751 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-12-03 [patent_title] => Antisense oligonucleotides for inducing exon skipping and methods of use thereof [patent_app_type] => reissue [patent_app_number] => 15/655646 [patent_app_country] => US [patent_app_date] => 2017-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 15757 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15655646 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/655646
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Jul 19, 2017 Issued
90/013986 PLACENTAL TISSUE GRAFTS Jul 13, 2017 Issued
Array ( [id] => 15066919 [patent_doc_number] => RE047691 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-11-05 [patent_title] => Antisense oligonucleotides for inducing exon skipping and methods of use thereof [patent_app_type] => reissue [patent_app_number] => 15/645842 [patent_app_country] => US [patent_app_date] => 2017-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20660 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645842 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/645842
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Jul 9, 2017 Issued
Array ( [id] => 16588594 [patent_doc_number] => RE048404 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2021-01-26 [patent_title] => Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor [patent_app_type] => reissue [patent_app_number] => 15/642307 [patent_app_country] => US [patent_app_date] => 2017-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 4305 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 210 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15642307 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/642307
Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor Jul 4, 2017 Issued
15/588382 COMPOSITIONS AND METHODS FOR TREATING RENAL DISEASE May 4, 2017 Abandoned
90/013940 DETECTION OF NUCLEIC ACID SEQUENCE DIFFERENCES USING COUPLED POLYMERASE CHAIN REACTIONS Apr 12, 2017 Issued
90/013937 DETECTION OF NUCLEIC ACID SEQUENCE DIFFERENCES USING COUPLED LIGASE DETECTION AND POLYMERASE CHAIN REACTIONS Apr 11, 2017 Issued
Array ( [id] => 13192929 [patent_doc_number] => RE047103 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-10-30 [patent_title] => Antibody drug conjugates (ADC) that bind to 158P1D7 proteins [patent_app_type] => reissue [patent_app_number] => 15/448507 [patent_app_country] => US [patent_app_date] => 2017-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 26 [patent_no_of_words] => 34539 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15448507 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/448507
Antibody drug conjugates (ADC) that bind to 158P1D7 proteins Mar 1, 2017 Issued
15/405171 METHOD FOR TREATING ONYCHOMYCOSIS Jan 11, 2017 Abandoned
Array ( [id] => 14084277 [patent_doc_number] => RE047320 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-03-26 [patent_title] => Modulation of CD40 expression [patent_app_type] => reissue [patent_app_number] => 15/386791 [patent_app_country] => US [patent_app_date] => 2016-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22018 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15386791 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/386791
Modulation of CD40 expression Dec 20, 2016 Issued
Array ( [id] => 15242481 [patent_doc_number] => RE047769 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-12-17 [patent_title] => Antisense oligonucleotides for inducing exon skipping and methods of use thereof [patent_app_type] => reissue [patent_app_number] => 15/349535 [patent_app_country] => US [patent_app_date] => 2016-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16555 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15349535 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/349535
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Nov 10, 2016 Issued
Array ( [id] => 15242479 [patent_doc_number] => RE047768 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-12-17 [patent_title] => Compositions and methods for the production of alpha-herpesviruses [patent_app_type] => reissue [patent_app_number] => 15/344216 [patent_app_country] => US [patent_app_date] => 2016-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 6060 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15344216 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/344216
Compositions and methods for the production of alpha-herpesviruses Nov 3, 2016 Issued
90/013857 GENETICALLY ENGINEERED OR TRANSGENIC RATS EXHIBITING A CANCER PHENOTYPE DUE TO A DISRUTPTION OF GERMLINE TUMOR SUPPRESSOR GENES Nov 2, 2016 Issued
Array ( [id] => 15223695 [patent_doc_number] => RE047761 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-12-10 [patent_title] => Anti-axl antibodies and methods of use [patent_app_type] => reissue [patent_app_number] => 15/287601 [patent_app_country] => US [patent_app_date] => 2016-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 39 [patent_no_of_words] => 40245 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15287601 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/287601
Anti-axl antibodies and methods of use Oct 5, 2016 Issued
Array ( [id] => 13941137 [patent_doc_number] => RE047245 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-02-19 [patent_title] => Pro-angiogenic peptides and uses thereof [patent_app_type] => reissue [patent_app_number] => 15/278016 [patent_app_country] => US [patent_app_date] => 2016-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 9021 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15278016 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/278016
Pro-angiogenic peptides and uses thereof Sep 26, 2016 Issued
15/268332 B7-H1 Antibodies and Method of Use Sep 15, 2016 Abandoned
Menu